Patents
Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
11/2004
11/18/2004US20040229860 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis
11/18/2004US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/11/2004WO2004096794A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs
11/11/2004WO2004096763A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
11/11/2004WO2004096287A2 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
11/11/2004WO2004096286A2 Antiviral phosphonate analogs
11/11/2004WO2004096236A2 Immunomodulator phosphonate conjugates
11/11/2004WO2004096235A2 Anti-cancer phosphonate analogs
11/11/2004CA2524251A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
11/11/2004CA2523083A1 Antiviral phosphonate analogs
11/11/2004CA2519840A1 Anti-cancer phosphonate analogs
11/10/2004CN1545555A Enzymatic resolution of t-butyl taxane derivatives
11/04/2004WO2004071454A3 Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
11/04/2004WO2004042351A3 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/04/2004US20040220191 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
11/04/2004DE10314610A1 Neues Diphenylazetidinon mit verbesserten physiologischen Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindungen enthaltende Arzneimittel und dessen Verwendung New diphenylazetidinone with improved physiological properties, process for its preparation, pharmaceutical compositions containing them and their use
10/2004
10/28/2004WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/27/2004EP1470137A1 Edg receptor agonists
10/27/2004CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/21/2004WO2004089885A1 Novel compounds
10/21/2004WO2004089876A1 Biphenylcarboxylic amide derivatives as p38 kinease inhibitors
10/21/2004US20040209846 Heterocyclic analgesic compounds and methods of use thereof
10/14/2004WO2004087655A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
10/14/2004WO2004087650A2 Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
10/14/2004US20040202734 Method for preparing nicotianamine or nicotianamine-containing product
10/14/2004CA2520689A1 Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
10/13/2004EP1465891A2 Inhibitors of dipeptidyl peptidase iv
10/13/2004EP1347987B1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
10/13/2004EP0999204B1 Novel compound having effect of promoting neuron differentiation
10/13/2004EP0934928B1 Cyclic amine derivatives
10/13/2004EP0736036B1 Kininogen inhibitors
10/13/2004CN1170842C New amidinobenzylamine derivatives and their use as thrombin inhibitors
10/07/2004WO2004033442A3 Novel taxanes and methods related to use and preparation thereof
10/07/2004US20040199005 Method for producing (R) -3- [4- (trifluoromethyl) phenylamino] -pentanoic acid amide derivative
10/07/2004US20040198700 Administering to a patient an azetidinone compound containing at least 3 phenyl rings fo rprevention of a vascular condition, diabetes, obesity, stroke, lowering a concentration of a sterol or stanol in plasma of a mammal, preventing demyelination or treating Alzheimer's disease
10/05/2004US6800766 Catalyzing the decyclization of racemic and diastereomeric epoxides mixtures in the presence of a non-racemic, chiral catalyst; pharmaceutical synthesis
10/05/2004CA2103837C Novel method of producing 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
09/2004
09/30/2004WO2004083166A1 Processes for production of (r)-3-[4-(trifluoromethyl)- phenylamino]pentanamide derivatives
09/30/2004WO2003051314A3 Antibiotic compounds
09/30/2004US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases
09/30/2004US20040192676 Ligands of melanocortin receptors and compositions and methods related thereto
09/30/2004CA2515789A1 Method for producing(r)-3-[4-(trifluoromethyl)phenylamino]-pentanoic acid amide derivative
09/29/2004EP1461315A2 Catalytic carbonylation of three and four membered heterocycles
09/29/2004EP1012140B1 New amidino derivatives and their use as thrombin inhibitors
09/28/2004US6797833 Taxane derivatives having a tricyclic or tetracyclic core; remarkable properties in vitro; valuable antileukemia, antitumor and anticarcinogenic agents; human cancer cell line comparable to that of taxol and taxotere
09/28/2004CA2299013C Neuropeptide y antagonists
09/23/2004WO2004081643A1 Lenslet array with polarization conversion
09/23/2004WO2004081002A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
09/23/2004WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same
09/23/2004US20040186090 New amidino derivatives and their use as thrombin inhibitors
09/23/2004US20040186088 Mercapto-cycloalkyl or heterocyclyl ring-sulfonyl-aryl or heteroaryl derivatives; preventing the cleavage Of tumor necrosis factor- alpha from cell membranes in mammal; treating autoimmune diseases, inflammation, inflammatory bowel disease, Crohn's disease, asthma, sepsis and septic shock
09/22/2004EP1458413A2 Pharmaceutical compositions based on azetidine derivatives
09/21/2004US6794523 Anticancer agents, antitumor agents; leukemia
09/21/2004US6794359 Vertebrate intestinal protein which absorbs cholesterol, its inhibitors and mehtod of identifying the same
09/16/2004WO2004058149A3 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles
09/15/2004EP1456393A1 Cyclisation process for the preparation of c-2 beta-lactam compounds
09/15/2004EP1456171A1 Substituted cyclohexane derivatives
09/15/2004EP0986384A4 Inhibitors of protein isoprenyl transferases
09/10/2004WO2004007444A3 N-hydroxyamide derivatives possessing antibacterial activity
09/09/2004DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments
09/08/2004EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
09/08/2004CN1527876A Compounds, compositions, and methods for controlling biofilms
09/08/2004CN1527707A The use of substituted azetidinone compounds for the treatment of sitosterolemia
09/07/2004US6787540 Compounds useful as reversible inhibitors of cysteine proteases
09/02/2004US20040171849 Halogenation a 4-amino-2-hydroxybutyric acid ; cyclization; in aqueous solution
08/2004
08/26/2004WO2004072025A2 Substituted n-arylheterocycles, method for production and use thereof as medicaments
08/26/2004WO2004071454A2 Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
08/26/2004US20040167115 induction apoptosis; Dna replication inhibition; p38 MAP kinase activation or caspase cascading activation, or cytochromic C release from mitochondria into cytoplasm
08/26/2004CA2516118A1 Substituted n-arylheterocycles, method for production and use thereof as medicaments
08/25/2004EP1448523A1 Heterocyclic compounds and methods of use
08/25/2004EP1278728B1 Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
08/24/2004US6780858 Hydroxyamidines and related compounds
08/19/2004WO2004069793A2 Novel 2-substituted cyclic amines as calcium sensing receptor modulators
08/12/2004US20040157823 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
08/12/2004US20040157822 Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1
08/11/2004EP1444200A1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1
08/11/2004EP1443922A1 Mch antagonists for the treatment of obesity
08/11/2004EP1140918B1 Thrombin inhibitors
08/04/2004EP1441728A2 Modulators of the cholesterol biosynthetic pathway
08/04/2004EP0667772B9 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
08/04/2004CN1518534A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
08/03/2004CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
07/2004
07/29/2004US20040147502 Beta lactam compounds and their use as inhibitors of tryptase
07/28/2004CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
07/28/2004CN1515563A Aryl substituted piperazine for curing benign prostatauxe
07/28/2004CN1515556A Intermediate compound for preparing aryl substituted piperazine
07/27/2004CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
07/22/2004US20040142999 Novel compounds and compositions as cathepsin inhibitors
07/22/2004US20040142986 Controlling transforming growth facor; artificial skin; wound healing agents
07/15/2004WO2004058735A2 Ligands of melanocortin receptors and compositions and methods related thereto
07/15/2004WO2004058149A2 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles
07/14/2004EP1436255A1 Novel compounds and compositions as cathepsin inhibitors
07/14/2004EP1436009A1 Pharmaceutical formulation
07/14/2004CN1512983A Compounds and compositions as cathepsins inhibitors
07/13/2004US6762309 Antileukemia and antitumor agents
07/13/2004US6762306 Chiral ligand
07/08/2004WO2004056766A1 Inhibitors of tace
07/08/2004US20040132991 Novel taxanes and methods related to use and preparation thereof
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 69